Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33010815.
- Also identified by DOI 10.1016/j.cell.2020.09.038 and PMC identifier 7494270.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Limited knowledge is available on the relationship between antigen-specific immune responses and COVID-19 disease severity. We completed a combined examination of all three branches of adaptive immunity at the level of SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell and neutralizing antibody responses in acute and convalescent subjects. SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells were each associated with milder disease. Coordinated SARS-CoV-2-specific adaptive immune responses were associated with milder disease, suggesting roles for both CD4<sup>+</sup> and CD8<sup>+</sup> T cells in protective immunity in COVID-19. Notably, coordination of SARS-CoV-2 antigen-specific responses was disrupted in individuals ≥ 65 years old. Scarcity of naive T cells was also associated with aging and poor disease outcomes. A parsimonious explanation is that coordinated CD4<sup>+</sup> T cell, CD8<sup>+</sup> T cell, and antibody responses are protective, but uncoordinated responses frequently fail to control disease, with a connection between aging and impaired adaptive immune responses to SARS-CoV-2.
Medical subject headings
- Adaptive Immunity
- Antigens, Viral
- Coronavirus Infections
- Pneumonia, Viral